Menu
IMMUPARKNET WG5 article entitled “IMMUnity Unveiled: A Translational NETwork for tackling PARKinson’s Disease – IMMUPARKNET” has just been published on Open Research Europe. The Open Letter...
It is with great pleasure that we anounce that Work Group 1’s IMMUPARKNET paper has been published in Brain, entitled: “The immune system in Parkinson’s...
This year IMMUPARKNET COST Action Annual Conference will take place in the beatiful city of Belgrade, Republic of Serbia, at the Royal Inn Hotel, from...
Last week, from 5 to 9 March, the groundbreaking series of Alzheimer’s and Parkinson’s disease (AD/PD 2024) conferences took place in Lisbon, at Centro de...
IMMUPARKNET call for applications for short-term scientific missions (STSMs), inclusiveness target countries (ITC) Conference Grants and Dissemination Grants is currently open! Further and detailed information...
IMMUPARKNET Second Annual Conference Grant Period 2 Location: Belgrade, SerbiaDate: 20th to 22nd April 2024 This event aims to host Action updates of all Working Group meetings, oral...
WG5 and IMMUPARKNET CA21117 COST Action invites you to join our first webinar session with Dr. Đorđe Miljković that will take place online on September 21st 2023, 3:00 pm (CET)....
A clinical PhD program in Experimental Medicine and Medical Humanities at the University of Insubria, Varese, Italy, is open for applications. The Ph.D. program is...
Dear IMMUPARKNET participants, The second call for grants for Grant Period 1 (from 01/11/2022 to 31/10/2023) is now open. The grant awarding committee will evaluate...
The 2nd meeting of IMMUPARKNET COST Action will take place from 15th to 17th of June 2023 in the sunny city of Seville, Spain. Venue: Instituto...
COST (European Cooperation in
Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
The Action focuses on Parkinson’s disease (PD) challenges and aims at establishing an innovative, multi-interdisciplinary Network, fostering the exchange of expertise among outstanding experts, from different countries and institutions, involving scientists studying immunity in PD but also immunity in other neurodegenerative diseases.
MoU – 031/22
CSO Approval date – 27/05/2022
Start date – 20/09/2022
End date – 19/09/2026
Design by Boutik
